Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Zalutumumab> ?p ?o. }
Showing items 1 to 52 of
52
with 100 items per page.
- Zalutumumab abstract "Zalutumumab (proposed trade name HuMax-EGFr) is a fully human IgG1 monoclonal antibody (mAb) directed towards the epidermal growth factor receptor (EGFr). It is a product developed by Genmab in Utrecht, the Netherlands. Specifically, zalutumumab is designed for the treatment of squamous cell carcinoma of the head and neck (SCCHN), a type of cancer. The current treatment for SCCHN includes tyrosine kinase inhibitors and human monoclonal antibodies. In addition, murine mAbs were tested successfully in mice, but caused an immune response in humans and were thus determined as ineffective in therapeutics.".
- Zalutumumab atcPrefix "none".
- Zalutumumab casNumber "667901-13-5".
- Zalutumumab wikiPageID "9701109".
- Zalutumumab wikiPageRevisionID "556330328".
- Zalutumumab atcPrefix "none".
- Zalutumumab c "6512".
- Zalutumumab casNumber "667901".
- Zalutumumab chemspiderid "NA".
- Zalutumumab h "10074".
- Zalutumumab hasPhotoCollection Zalutumumab.
- Zalutumumab kegg "D10031".
- Zalutumumab mabType "mab".
- Zalutumumab molecularWeight "148".
- Zalutumumab n "1734".
- Zalutumumab o "2032".
- Zalutumumab s "46".
- Zalutumumab source "u".
- Zalutumumab target Epidermal_growth_factor_receptor.
- Zalutumumab type "mab".
- Zalutumumab verifiedfields "changed".
- Zalutumumab verifiedrevid "470635509".
- Zalutumumab subject Category:Monoclonal_antibodies_for_tumors.
- Zalutumumab type Abstraction100002137.
- Zalutumumab type Antibody115027189.
- Zalutumumab type Chemical114806838.
- Zalutumumab type Compound114818238.
- Zalutumumab type Macromolecule114944888.
- Zalutumumab type Material114580897.
- Zalutumumab type Matter100020827.
- Zalutumumab type Molecule114682133.
- Zalutumumab type MonoclonalAntibodiesForTumors.
- Zalutumumab type MonoclonalAntibody115029781.
- Zalutumumab type OrganicCompound114727670.
- Zalutumumab type Part113809207.
- Zalutumumab type PhysicalEntity100001930.
- Zalutumumab type Protein114728724.
- Zalutumumab type Relation100031921.
- Zalutumumab type Substance100019613.
- Zalutumumab type Thing100002452.
- Zalutumumab type Unit109465459.
- Zalutumumab type Drug.
- Zalutumumab type DrugProduct.
- Zalutumumab type FunctionalSubstance.
- Zalutumumab comment "Zalutumumab (proposed trade name HuMax-EGFr) is a fully human IgG1 monoclonal antibody (mAb) directed towards the epidermal growth factor receptor (EGFr). It is a product developed by Genmab in Utrecht, the Netherlands. Specifically, zalutumumab is designed for the treatment of squamous cell carcinoma of the head and neck (SCCHN), a type of cancer. The current treatment for SCCHN includes tyrosine kinase inhibitors and human monoclonal antibodies.".
- Zalutumumab label "Zalutumumab".
- Zalutumumab sameAs m.02ppk_l.
- Zalutumumab sameAs Q8065569.
- Zalutumumab sameAs Q8065569.
- Zalutumumab sameAs Zalutumumab.
- Zalutumumab wasDerivedFrom Zalutumumab?oldid=556330328.
- Zalutumumab isPrimaryTopicOf Zalutumumab.